Global GLP-1 Receptor Agonist Industry will surpass the US$ 11.24 Billion by 2032, driven by the ris
Global GLP-1 Receptor Agonist IndustryThe global GLP-1 Receptor Agonist Industry has been experiencing remarkable growth in recent years, and this trend shows no signs of slowing down. GLP-1 receptor agonists are a class of medications primarily used to treat type 2 diabetes mellitus, but their therapeutic potential...
Source: pharmiweb.com